Abstract
The improved understanding of the biochemical nature of tumor antigens and the identification of cellular and molecular mechanisms leading to activation of innate and adaptive immune cells have been of paramount importance in the progress of tumor immunology. Studies on the intricate network of interactions between tumor and immune cells have revealed novel regulatory signals, including cell surface inhibitory receptors and costimulatory molecules, intracellular regulatory pathways, immunosuppressive cytokines and proapoptotic mediators, which may operate in concert to orchestrate tumor-immune escape. This emerging portfolio of inhibitory checkpoints can influence the physiology of innate immune cells including dendritic cells, macrophages and natural killer (NK) cells, as well as different subsets of T cells to fine tune their effector function. The synergistic combination of strategies aimed at overcoming regulatory signals and/or stimulating effector pathways, may offer therapeutic advantage as adjuvants of conventional anticancer therapies. Based on this premise, we will discuss here how the control of the effector functions of innate and adaptive immune cells and the manipulation of regulatory pathways, either alone or in ...Continue Reading
Citations
Jun 21, 2011·Seminars in Immunopathology·Douglas D Taylor, Cicek Gercel-Taylor
Jan 14, 2012·Cancer Biotherapy & Radiopharmaceuticals·Kwan-Hwa ChiShang-Jyh Kao
Mar 20, 2012·Trends in Molecular Medicine·Shigeru TsuboiMinoru Fukuda
Sep 6, 2011·Cellular Immunology·Liudmila A ZakharovaLiudmila N Ivanova
Mar 26, 2011·Biotechnology Advances·Jianfeng GuoCaitriona O'Driscoll
Jul 14, 2010·BioFactors·Norberto W Zwirner, Carolina I Domaica
Apr 26, 2011·Molecular Oncology·Mariana MalviciniGuillermo Mazzolini
Feb 8, 2011·International Immunopharmacology·Iván D MascanfroniGabriel A Rabinovich
Mar 16, 2011·Cell Host & Microbe·Daniel L PopkinMichael Oldstone
Jul 25, 2015·Nature Reviews. Cancer·Ignacio MeleroJohn Haanen
Aug 31, 2014·Doklady. Biochemistry and Biophysics·V I MelnikovaL N Ivanova
Dec 22, 2016·Oncotarget·Eonju OhChae-Ok Yun
Dec 4, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Edwin J Vazquez-CintronAlan B Frey
Jun 4, 2010·Expert Review of Vaccines·Silvia von Mensdorff-Pouilly
Feb 13, 2018·Oncotarget·Wen ZhangJunnian Zheng